- freely available
Int. J. Mol. Sci. 2012, 13(12), 15565-15574; doi:10.3390/ijms131215565
Published: 22 November 2012
Abstract: The effects of temperature on the operation of two ion-coupled cotransporters of the SLC6A family, namely rat GAT1 (SLC6A1) and KAAT1 (SLC6A19) from Manduca sexta, have been studied by electrophysiological means in Xenopus laevis oocytes expressing these proteins. The maximal transport-associated current (Imax) and the apparent substrate affinity (K05) were measured. In addition to the expected increase in transport rate (Q10 = 3–6), both transporters showed greater K05 values (i.e., a decrease in apparent affinity) at higher temperatures. The transport efficiency, estimated as Imax/K05, increased at negative potentials in both transporters, but did not show statistically significant differences with temperature. The observation that the apparent substrate affinity is inversely related to the transport rate suggests a kinetic regulation of this parameter. Furthermore, the present results indicate that the affinities estimated at room temperature for mammalian cotransporters may not be simply extrapolated to their physiological operating conditions.
Functional studies of ion-coupled cotransporters have strongly taken advantage of the possibility of heterologous expression in Xenopus oocytes, which may be studied with relatively simple electrophysiological techniques, such as the two-electrode voltage-clamp (TEVC). This approach suffers, however, of an important drawback when mammalian transporters are investigated, because temperatures above 30 °C are not easily tolerated by the oocytes, and therefore, most studies have been performed at room temperature (20 to 25 °C) [1–4].
In the relatively few papers reporting the effects of temperature on the activity of cotransporters [5–9], the focus of the observations was generally on the rate of transport and on the effects on the presteady-state currents, i.e., the electrical signal arising from the initial steps of the transport cycle [1,10,11]. In a recent work from our laboratory on the rabbit intestinal oligopeptide transporter PepT1 , we observed that the apparent substrate affinity was significantly affected by temperature. In particular, a decrease in apparent affinity was measured in the physiological voltage range when increasing the temperature from 20 to 30 °C. This effect was associated with a strong increase in the maximal transport current and with an acceleration of the kinetics of the presteady-state currents. All together, these observations point to a kinetic interpretation of the apparent substrate affinity in which a greater substrate concentration is required to keep up with the ability of a faster turnover of the transporter. In fact, we have already reported this kind of relationship in the GABA transporter GAT1 [13–16].
To better investigate these points, we have studied the effects of temperature on the apparent substrate affinity in two other transporters, namely the rat neuronal GABA transporter GAT1 and the neutral amino acid transporter KAAT1, cloned from the gut of the invertebrate Manduca sexta. The aim of the investigation was first of all to verify if the apparent substrate affinity was similarly affected by temperature and, secondarily, to examine the overall efficiency of the transport, considering in addition that, while rGAT1 (and PepT1) are from mammalian (homeotherm) animals, KAAT1 originates from a poikilotherm invertebrate .
2. Results and Discussion
2.1. Apparent Affinity Changes Induced by Temperature in rGAT1
For these experiments, a staircase voltage protocol was used to minimize temperature fluctuations during the recording . For rGAT1, the protocol was applied from a holding potential (Vh) = −40 mV and consisted of five steps spanning the range from −120 to +40 mV in 40 mV intervals. The steps were 400 ms in duration to allow for the complete decline of the presteady-state currents, particularly at the lower temperature. The current traces in response to this protocol at 20 and 30 °C are shown in Figure 1A,B, in the absence or presence of GABA 300 μM. As expected [4,19,20], the presteady-state currents visible in the absence of GABA (arrows) are abolished by its addition. It may be noted that these currents are strongly accelerated at the higher temperature, and accordingly, the transport-associated currents become significantly larger. Dose-response experiments were performed in a series of oocytes at these two temperatures in order to obtain the values of the maximal transport current (Imax) and of the substrate concentration, eliciting the half-maximal current (K05) by fitting the data to the Michaelis-Menten equation:
Figure 1C,D show the results of this analysis: Imax is strongly increased at 30 °C compared to 20 °C; the Q10 of the effect is variable with voltage from 2.7 at −40 mV up to almost 6 at −120 mV. This value is higher than those reported before [6,7], however, it must be noted that the previous data were obtained using a fixed GABA concentration and therefore, did not account for changes in apparent affinity. Indeed, the effect of temperature on K05 may be seen in Figure 1D: at 20 °C, this parameter is voltage-dependent as previously reported [13,19,20], and increases at negative potentials, with values between 5 and 20 μM. At 30 °C, and in the same oocytes, K05 is significantly larger at all potentials, while the voltage-dependence is qualitatively maintained.
2.2. Apparent Affinity Changes Induced by Temperature in KAAT1
The same kind of experiments was repeated in another transporter, the Manduca sexta intestinal transporter KAAT1. Although clearly not a neurotransmitter transporter, this protein has a significant homology with the mammalian neutral amino acid transporter B0AT1, another member of the SLC6A family [21,22]. KAAT1 shows several distinct features, among which is the capability to accept various neutral amino acid as substrates and to use potassium as a driving ion .
In this case, threonine was used as a substrate, since this amino acid elicits a large transport current in KAAT1 when the driving ion is sodium .
The results of these experiments are shown in Figure 2. In this case, the holding potential was kept at −60 mV, and the voltage protocol covered the interval −140 to +20 mV to account for the more negative operating range of this transporter . The staircase consisted of nine 20 mV steps of shorter duration compared to those used for rGAT1, because the decline of the presteady-state currents is much faster in this transporter.
Dose-response curves were obtained in this case as well, and the data analyzed with the Michaelis-Menten equation (Equation 1). As illustrated in Figure 2C, raising the temperature from 20 to 30 °C produces a considerable increase in Imax, which is, however, not as large as in the case of rGAT1 (Figure 1C), but is, instead, similar to that observed in the oligopeptide transporter PepT1 , with Q10 values between 3 and 4. The action of temperature on K05 is shown in Figure 2D. It may be noted that the voltage-dependence of this parameter at 20 °C is different from that exhibited by rGAT1 (Figure 1D), i.e., it shows an increase at more positive potentials, rather than a decrease; in fact this behavior confirms previous determinations , and it is very likely related to the different characteristics of the presteady-state currents in the two transporters [11,16]. Concerning the effect of temperature, a significant increase in the value of K05 is evident at 30 °C, compared to 20 °C, although, in analogy with Figure 1D, the shape of the curve is qualitatively unchanged.
The results illustrated above for rGAT1 and KAAT1 confirm the effect already observed in rabbit PepT1  and suggest that a change in apparent affinity with temperature might be a feature shared by different transporters, even those belonging to diverse gene families. It must be noted, however, that some results indicating no significant effects have been also reported in other transporters .
2.3. Overall Efficiency
The increase in Imax and the decrease in apparent affinity reported above will counteract each other in determining the overall efficiency of the process. According to enzyme kinetics criteria , this parameter may be estimated as the ratio Imax/K05, and it is plotted in Figure 3 for the two transporters.
In both cases, the transport efficiency increases as the membrane potential is made more negative. However, no statistically significant differences between 20 and 30 °C are observed in both transporters, especially in the physiological range of membrane potentials, around −70 mV for a neuronal presynaptic membrane, or surrounding glial cells, where rGAT1 is generally located, and at about −200 mV for the luminal side of absorptive intestinal cells, in the case of KAAT1 .
3. Experimental Section
3.1. Oocyte Expression
Oocytes and RNAs were prepared as previously described in detail . Briefly, to prepare the mRNA, the cDNA encoding the rGAT1 and KAAT1 proteins cloned into the pAMV vector (generous gift from C. La Barca and H. Lester) were linearized with NotI; cRNAs were then synthesized in vitro in the presence of Cap Analog and 200 units of T7 RNA polymerase. All enzymes were supplied by Promega Italia (Milan, Italy). Adult female Xenopus laevis (Xenopus Express, Le Bourg, Vernassal, Haute-Loire, France) were anaesthetized in MS222 (tricaine methansulfonate, Sigma-Aldrich srl, Milan, Italy) 0.10% (w/v) solution in tap water, and portions of the ovary were removed through an incision on the abdomen. These procedures were carried out according to institutional and national ethical guidelines (permit no12/09). The oocytes were treated with collagenase Type IA, (Sigma-Aldrich srl, Milan, Italy) 1 mg/mL in calcium-free ND96, for at least 1 h at 18 °C. After 24 h at 18 °C in modified Barth’s saline solution (MBS), selected oocytes were injected with 12.5 ng of cRNA in 50 nL of water, using a manual microinjection system (Drummond Scientific Company, Broomall, PA, USA). The oocytes were then incubated at 18 °C for 3–4 days in MBS before electrophysiological studies.
3.2. Electrophysiology and Data Analysis
Transport activity was estimated in terms of the transmembrane current generated under voltage control, using the two-electrode voltage-clamp technique (TEVC, Oocyte Clamp OC-725B, Warner Instruments, Hamden, CT, USA). Intracellular glass microelectrodes were filled with KCl 3 M and had tip resistances between 0.5–4 MΩ. Agar bridges (3% agar in 3 M KCl) connected the bath electrodes to the experimental chamber.
The experiments were run under the WinWCP version 4.4.6 software (J. Dempster, University of Strathclyde, UK, 2012). Data were analyzed using Clampfit 10.2 (Molecular Devices, LLC, Sunnyvale, CA, USA, 2012), while figures were prepared with Origin 8.0 (OriginLab Corp., Northampton, MA, USA, 2008).
As usual, the transport-associated current was obtained by subtracting the records in the absence of substrate from those in its presence.
3.3. Temperature Control
Cold solutions in the reservoirs were heated to the desired temperature just before entering the recording chamber. A TC-344A in-line heater controller (Warner Instr. Corp., Hamden, CT, USA) with feedback control of the temperature was used. The actual temperature in close proximity of the oocyte was continuously monitored through a second thermistor placed in the bath. The effects of small temperature oscillations were minimized by using short-duration protocols, such as the voltage staircases mentioned in the Results and Discussion section.
The oocyte culture and washing solutions had the following composition (in mM): ND96: NaCl 96, KCl 2, MgCl2 1, CaCl2 1.8, Hepes 5, pH 7.6; MBS: NaCl 88, KCl 1, NaHCO3 2.4, Hepes 15, Ca(NO3)2 0.30, CaCl2 0.41, MgSO4 0.82, sodium penicillin 10 μg/mL, streptomycin sulphate 10 μg/mL, gentamycin sulphate 100 μg/mL, nystatin 10 U/mL, pH 7.6; PBS: NaCl 138, KCl 2.7, Na2HPO4, KH2PO4, pH 7.6.
The external control solution during the electrophysiological recordings had the following composition (mM): NaCl, 98; MgCl2, 1; CaCl2, 1.8, Mes 5 mM. The final pH value (7.6) was adjusted with HCl and NaOH.
The substrates were added to this solution at the desired concentrations. For the dose-response experiments, the GABA concentrations were 1, 3, 10, 30, 100 and 300 μM; the threonine concentrations were 3, 10, 30, 100, 300 and 1000 μM.
All ion-coupled cotransporters tested so far to investigate the effects of temperature have shown changes in transport activity with Q10 values of about three or more [5–8,12,29]. These large effects, imply high activation energies for the rate-limiting step in the process, in the range of several tens of kiloJoules per mole (kJ/mol) and confirm, therefore, that the transport process must involve a relevant conformational change of the protein.
For mammalian transporters, the observations obtained in these studies might lead to the expectation that, at their physiological body temperature, they might be much more efficient in substrate translocation. However, the overall transport efficiency will obviously depend on another property of the transporter: its apparent affinity for the substrate.
Relatively little attention has been paid to this second aspect, and published reports are scarce. Some results implying a decrease in apparent affinity at low temperatures can be found in an earlier paper on the noradrenaline transporter , and subsequently, similar results were reported in the Drosophila serotonin transporter . On the contrary, no temperature-induced changes in apparent affinity were observed in the human form of GAT1 . In a recent study on the intestinal PepT1 transporter from our laboratory , we confirmed the earlier observations, and we show here that two other cotransporters, the rat neuronal GABA transporter GAT1 implied in many important physiopathological issues, and the invertebrate intestinal amino acid transporter KAAT1, also exhibit this same feature.
The explanation for this behavior may be directly found in the transport mechanism, which for the transporters under consideration appears very similar [13,24,31,32]. In these transporters, in fact, the initial steps of the cycle, involving the interaction with the driving ion(s) and the following intramembrane charge movement, precede the binding of the organic substrate. Furthermore, these steps are rate-limiting of the entire transport cycle [31–33]. Consequently, the lifetime of the conformational state in which substrate binding can occur will be shortened when the turnover rate is increased (e.g., in the present case, by a higher temperature). A shorter life time of this state implies that a higher concentration of substrate will be needed to sustain the high turnover rate, leading therefore to a decreased apparent affinity.
The membrane composition of the Xenopus oocyte is unlikely to be the same of a mammalian or of a Manduca cell, and therefore, the present results cannot be directly extrapolated to the respective native conditions. We show here that the increased Imax at higher temperature is counterbalanced by a lower apparent affinity, and that in both rGAT1 and KAAT1, the two effects approximately compensate for each other, so that the efficiency, estimated as the ratio Imax/K05, appears substantially temperature-independent. However, in the case of the GABA transporter, the lower apparent affinity at higher temperature is likely to produce consequences on the basal extracellular levels of the neurotransmitter, which are known to be very important in neurological pathophysiology [34,35].
We are very grateful to Raffaella Cinquetti for her skillful technical assistance.
- Parent, L.; Supplisson, S.; Loo, D.D.F.; Wright, E.M. Electrogenic properties of the cloned Na+/glucose transporter: I. Voltage-clamp studies. J. Membr. Biol 1992, 125, 49–62.
- Forster, I.C.; Virkki, L.; Bossi, E.; Murer, H.; Biber, J. Electrogenic kinetics of a mammalian intestinal type IIb Na+/Pi cotransporter. J. Membr. Biol 2006, 212, 177–190.
- Pérez-Siles, G.; Núñez, E.; Morreale, A.; Jiménez, E.; Leo-Macías, A.; Pita, G.; Cherubino, F.; Sangaletti, R.; Bossi, E.; Ortìz, Á.; et al. An aspartate residue in the external vestibule of glycine transporter 2 (GLYT2) controls cation access and transport coupling. Biochem. J. 2012, 442, 323–334.
- Mager, S.; Kleinberger-Doron, N.; Keshet, G.I.; Davidson, N.; Kanner, B.I.; Lester, H.A. Ion binding and permeation at the GABA transporter GAT1. J. Neurosci 1996, 16, 5405–5414.
- Hazama, A.; Loo, D.D.F.; Wright, E.M. Presteady-state currents of the rabbit Na+/glucose cotransporter (SGLT1). J. Membr. Biol 1997, 155, 175–186.
- Binda, F.; Bossi, E.; Giovannardi, S.; Forlani, G.; Peres, A. Temperature effects on the presteady-state and transport-associated currents of GABA cotransporter rGAT1. FEBS Lett 2002, 512, 303–307.
- Hilgemann, D.W.; Lu, C.-C. GAT1 (GABA:Na+:Cl−) cotransport function. Database reconstruction with an alternating access model. J. Gen. Physiol 1999, 114, 459–475.
- Beckman, M.L.; Quick, M.W. Substrates and temperature differentiate ion flux from serotonin flux in a serotonin transporter. Neuropharmacology 2001, 40, 526–535.
- Bacconi, A.; Ravera, S.; Virkki, L.V.; Murer, H.; Forster, I.C. Temperature dependence of steady-state and presteady-state kinetics of a type IIb Na+/Pi cotransporter. J. Membr. Biol 2007, 215, 81–92.
- Mager, S.; Cao, Y.; Lester, H.A. Measurement of transient currents from neurotransmitter transporters expressed in Xenopus oocytes. Methods Enzymol 1998, 296, 551–566.
- Bossi, E.; Centinaio, E.; Castagna, M.; Giovannardi, S.; Vincenti, S.; Sacchi, V.F.; Peres, A. Ion binding and permeation through the lepidopteran amino acid transporter KAAT1 expressed in Xenopus oocytes. J. Physiol 1999, 515, 729–742.
- Bossi, E.; Cherubino, F.; Margheritis, E.; Oyadeyi, A.S.; Vollero, A.; Peres, A. Temperature effects on the kinetic properties of the rabbit intestinal oligopeptide cotransporter PepT1. Pflugers Arch 2012, 464, 183–191.
- Fesce, R.; Giovannardi, S.; Binda, F.; Bossi, E.; Peres, A. The relation between charge movement and transport-associated currents in the GABA cotransporter rGAT1. J. Physiol 2002, 545, 739–750.
- Peres, A.; Giovannardi, S.; Bossi, E.; Fesce, R. Electrophysiological insights on the mechanism of ion-coupled cotransporters. News Physiol. Sci 2004, 19, 80–84.
- Giovannardi, S.; Fesce, R.; Bossi, E.; Binda, F.; Peres, A. Cl− effects on the function of the GABA cotransporter rGAT1 preserve the mutual relation between transient and transport currents. CMLS 2003, 60, 550–556.
- Soragna, A.; Bossi, E.; Giovannardi, S.; Pisani, R.; Peres, A. Relations between substrate affinities and charge equilibration rates in the GABA cotransporter rGAT1. J. Physiol 2005, 562, 333–345.
- Castagna, M.; Shayakul, C.; Trotti, D.; Sacchi, V.F.; Harvey, W.R.; Hediger, M.A. Cloning and characterization of a potassium-coupled amino acid transporter. Proc. Natl. Acad. Sci. USA 1998, 95, 5395–5400.
- Castagna, M.; Bossi, E.; Sacchi, V.F. Molecular physiology of the insect K-activated amino acid transporter 1 (KAAT1) and cation-anion activated amino acid transporter/channel 1 (CAATCH1) in the light of the structure of the homologous protein LeuT. Ins. Mol. Biol 2009, 18, 265–279.
- Mager, S.; Naeve, J.; Quick, M.; Labarca, C.; Davidson, N.; Lester, H.A. Steady states, charge movements, and rates for a cloned GABA transporter expressed in Xenopus oocytes. Neuron 1993, 10, 177–188.
- Forlani, G.; Bossi, E.; Ghirardelli, R.; Giovannardi, S.; Binda, F.; Bonadiman, L.; Ielmini, L.; Peres, A. Mutation K448E in the external loop 5 of rGAT1 transporter induces pH sensitivity and altered substrates interactions. J. Physiol 2001, 536, 479–494.
- Boudko, D.Y.; Kohn, A.B.; Meleshkevitch, E.A.; Dasher, M.K.; Seron, T.J.; Stevens, B.R.; Harvey, W.R. Ancestry and progeny of nutrient amino acid transporters. Proc. Natl. Acad. Sci. USA 2005, 102, 1360–1365.
- Camargo, S.M.R.; Makrides, V.; Virkki, L.V.; Forster, I.C.; Verrey, F. Steady-state kinetic characterization of the mouse B0AT1 sodium-dependent neutral amino acid transporter. Pflugers Arch 2005, 451, 338–348.
- Soragna, A.; Mari, S.; Peres, A.; Pisani, R.; Castagna, M.; Sacchi, V.F.; Bossi, E. Structural domains involved in substrate selectivity in two neutral amino acid transporters. Am. J. Physiol. Cell Physiol 2004, 287, C754–C761.
- Miszner, A.; Peres, A.; Castagna, M.; Betté, S.; Giovannardi, S.; Cherubino, F.; Bossi, E. Structural and functional basis of amino acid specificity in the invertebrate cotransporter KAAT1. J. Physiol 2007, 581, 899–913.
- Gonzales, A.L.; Lee, W.; Spencer, S.R.; Oropeza, R.A.; Chapman, J.V.; Ku, J.Y.; Eskandari, S. Turnover rate of the gamma-aminobutyric acid transporter GAT1. J. Membr. Biol 2007, 220, 33–51.
- Stryer, L. Biochemistry, 3rd. Ed ed.; W.H. Freeman and Company: New York, NY, USA; p. 1988.
- Dow, J.A.T.; Peacock, J.M. Microelectrode evidence for the electrical isolation of goblet cell cavities in Manduca sexta middle midgut. J. Exp. Biol 1989, 143, 101–114.
- Bossi, E.; Fabbrini, M.S.; Ceriotti, A. Exogenous protein expression in Xenopus Laevis oocyte, basic procedure. Methods Mol. Biol 2007, 375, 107–131.
- Zeuthen, T.; MacAulay, N. Cotransport of water by Na+-K+-2Cl− cotransporters expressed in Xenopus oocytes: NKCC1 versus NKCC2. J. Physiol 2012, 590, 1139–1154.
- De Oliveira, A.M.; Shoemaker, H.; Segonzac, A.; Langer, S.Z. Differences in the temperature dependence of drug interaction with the noradrenaline and serotonin transporters. Neuropharmacology 1989, 28, 823–828.
- Sala-Rabanal, M.; Loo, D.D.F.; Hirayama, B.A.; Turk, E.; Wright, E.M. Molecular interactions between dipeptides, drugs and the human intestinal H+/oligopeptide cotransporter, hPEPT1. J. Physiol 2006, 574, 149–166.
- Renna, M.D.; Sangaletti, R.; Bossi, E.; Cherubino, F.; Kottra, G.; Peres, A. Unified modeling of the mammalian and fish proton-dependent oligopeptide transporter PepT1. Channels 2011, 5, 89–99.
- Nussberger, S.; Steel, A.; Trotti, D.; Romero, M.F.; Boron, W.F.; Hediger, M.A. Symmetry of H+ binding to the intra- and extracellular side of the H+-coupled oligopeptide cotransporter PepT1. J. Biol. Chem 1997, 272, 7777–7785.
- Richerson, G.B.; Wu, Y. Dynamic equilibrium of neurotransmitter transporters: Not just for reuptake anymore. J. Neurophysiol 2003, 90, 1363–1374.
- Richerson, G.B.; Wu, Y. Role of the GABA transporter in epilepsy. Adv. Exp. Med. Biol 2004, 548, 76–91.
© 2012 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).